Effective gene therapy with nonintegrating lentiviral vectors
The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
Retroviral and lentiviral vector integration into host-cell chromosomes carries with it a finite chance of causing insertional mutagenesis. This risk has been highlighted by the induction of malignancy in mouse models, and development of lymphoproliferative disease in three individuals with severe combined immunodeficiency-X1 (refs. 2,3). Therefore, a key challenge for clinical therapies based on retroviral vectors is to achieve stable transgene expression while minimizing insertional mutagenesis. Recent in vitro studies have shown that integration-deficient lentiviral vectors can mediate stable transduction. With similar vectors, we now show efficient and sustained transgene expression in vivo in rodent ocular and brain tissues. We also show substantial rescue of clinically relevant rodent models of retinal degeneration. Therefore, the high efficiency of gene transfer and expression mediated by lentiviruses can be harnessed in vivo without a requirement for vector integration. For therapeutic application to postmitotic tissues, this system substantially reduces the risk of insertional mutagenesis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“NILVs encoding for in vivo expression of GFP have been reported in organs such as the brain, liver, and spinal cord via stable gene transfer for longer periods (up to months) in several studies [22,73,131,132,133,134].”
From Non-Integrating Lentiviral Vectors in Clinical Applications: A Glance Through (2022) · cites this paper as [22]
In the citing paper
“A non-integrating LV was engineered to avoid unwanted integration. In these vectors, selected mutations were induced within the integrase coding region to eliminate the integrase activities without affecting reverse transcription and transport of the pre-integrating complex into the nucleus [48,49,50].”
From Viral Delivery Systems for CRISPR (2019) · cites this paper as [49]
Citations
Cites
In Vivo Gene Delivery and Stable Transduction of Nondividing Cells by a Lentiviral Vector
Naldini, L., Blömer, U., Gallay, P., Ory, D., Mulligan, R., Gage, F. H., Verma, I. M., & Trono, D. (1996) · Science · doi:10.1126/science.272.5259.263 · Cited by 4,903 · cited 1×
“Class I integration-deficient lentiviral vectors have been reported to be inefficient for transduction of dividing cells in vitro”
BackgroundLMO2 -Associated Clonal T Cell Proliferation in Two Patients after Gene Therapy for SCID-X1
Hacein-Bey-Abina, S., Von Kalle, C., Schmidt, M., McCormack, M. P., Wulffraat, N., Leboulch, P., Lim, A., Osborne, C. S., Pawliuk, R., Morillon, E., et al. (2003) · Science · doi:10.1126/science.1088547 · Cited by 3,587
Self-citationA Third-Generation Lentivirus Vector with a Conditional Packaging System
Dull, T., Zufferey, R., Kelly, M., Mandel, R. J., Nguyen, M., Trono, D., & Naldini, L. (1998) · Journal of Virology · doi:10.1128/jvi.72.11.8463-8471.1998 · Cited by 3,341 · cited 1×
“We produced paired integration-proficient and integration-deficient HIV-1 vectors using self-inactivating system”
MethodNaldini, L., Blömer, U., Gage, F. H., Trono, D., & Verma, I. M. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.21.11382 · Cited by 1,499 · cited 1×
“In contrast, direct administration of nonintegrating vectors based on human immunodeficiency virus (HIV) or feline immunodeficiency virus (FIV) has not previously resulted in significant expression in vivo”
BackgroundA quantitative assay for HIV DNA integration in vivo
Butler, S. L., Hansen, M. S. T., & Bushman, F. D. (2001) · Nature Medicine · doi:10.1038/87979 · Cited by 687 · cited 1×
“We carried out qPCR titrations of total vector DNA according to a published protocol for late reverse transcriptase amplicon quantificatio”
MethodMurine leukemia induced by retroviral gene marking
Li, Z., Düllmann, J., Schiedlmeier, B., Schmidt, M., von Kalle, C., Meyer, J., Forster, M., Stocking, C., Wahlers, A., Frank, O., et al. (2002) · Science · doi:10.1126/science.1068893 · Cited by 525 · cited 1×
“We designed three different LAM-PCR reactions to scan vector regions downstream of the 5¢-dLTR (1), upstream of the 3¢-dLTR (2) and downstream of residual env sequences (a region including cPPT/CTS and internal promoter, 3) for integration junctions.”
MethodSelf-citationDemaison, C., Parsley, K., Brouns, G., Scherr, M., Battmer, K., Kinnon, C., Grez, M., & Thrasher, A. J. (2002) · Human Gene Therapy · doi:10.1089/10430340252898984 · Cited by 486
Self-citationSide effects of retroviral gene transfer into hematopoietic stem cells
Baum, C., Düllmann, J., Li, Z., Fehse, B., Meyer, J., Williams, D. A., & von Kalle, C. (2003) · Blood · doi:10.1182/blood-2002-07-2314 · Cited by 435
Case, S. S., Price, M. A., Jordan, C. T., Yu, X. J., Wang, L., Bauer, G., Haas, D. L., Xu, D., Stripecke, R., Naldini, L., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.6.2988 · Cited by 386
Shank, P. R., Hughes, S. H., Kung, H.-J., Majors, J. E., Quintrell, N., Guntaka, R. V., Bishop, J. M., & Varmus, H. E. (1978) · Cell · doi:10.1016/0092-8674(78)90063-6 · Cited by 383
Cited by
Items 401–459 of 459
Gene therapy for Stargardt and other ABCA4-related diseases: lessons from RPE65-LCA trials
Silva, N. F. A. (2010) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · Cited by 1
Gene Delivery to Cardiovascular Tissue
Masson, R., Nicklin, S. A., & Baker, A. H. (2009) · Springer eBooks · doi:10.1007/978-1-84882-637-3_2 · Cited by 1
Viral vector-mediated RNA interference in the retina
Georgiadis, A. (2010) · UCL Discovery (University College London)
Karwacz, K. (2012) · UCL Discovery (University College London)
Integrating Viral Vectors for Gene Modifications
Mendel, G. L., Paszkiet, B., & Witek, R. P. (2011) · Wiley eBooks · doi:10.1002/9781118147177.ch9
Schneider, B. L., Gaugler, M. N. M., & Aebischer, P. (2008) · Elsevier eBooks · doi:10.1016/b978-0-12-374028-1.00020-8
Development of Methods for Retinal Ganglion Cell Replacement in Glaucoma
Jones, M. F. (2013) · UCL Discovery (University College London)
Viren als Werkzeuge der Gentherapie. Wie aus einem Retrovirus ein Gentransfer‐Vektor entsteht
Thiel, G., & Rößler, O. G. (2007) · Biologie in unserer Zeit · doi:10.1002/biuz.200610340
Retroviruses for Cancer Therapy
Zhou, J., Ding, Y., Burnett, J., & Rossi, J. J. (2014) · Wiley eBooks · doi:10.1002/9781118501665.ch2
HIV Gene Therapy That’s Not a SIN
Lin, M., Sivakumaran, H., & Harrich, D. (2010) · HIV Therapy · doi:10.2217/hiv.10.32
Novel AAV-mediated Therapeutic Strategies for Epilepsy
Foti, S. B. (2008) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/wakz-r188
Assessing the potential of non-integrating lentiviral vectors for cardiovascular gene therapy
Chick, H. E. (2011) · Enlighten: Theses (The University of Glasgow) · doi:10.5525/gla.thesis.3045
Integrase minus lentiviral vector: A suitable vector for β-thalassemia gene targeting
Inanlou, D. N., Yakhchali, B., Khanahmad, H., Gardaneh, M., Hesam, M., Farazmandfar, T., Barazandeh, A., & Sirous, Z. (2009)
Factors affecting the formation, stability, and expression of unintegrated lentiviral vector genomes
Bayer, M. (2010) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/j9mp-1c47
Reconstitution and Characterization of Human Endogenous Retrovirus-K
Lee, Y. N. (2010) · Digital Commons - RU (Rockefeller University) · doi:10.48496/38w4-yp24 · Cited by 2
Gene Delivery Technologies for Efficient Genome Editing: Applications in Gene Therapy
Martín, F., Sánchez-Hernández, S., Gutiérrez-Guerrero, A., & Benabdellah, K. (2016) · InTech eBooks · doi:10.5772/62776 · Cited by 1
“Delivery of RGNs and TALENs by IDLVs has been more challenging due to the larger size of Cas9 and the high recombination rates of TALENs [40].”
BackgroundInfluentialImprovement of adoptive T-cell therapy for Cancer
Jin, C. (2016) · DiVA (Digitala Vetenskapliga Arkivet) · Cited by 1
Heron, A. L., Patterson, S., Yáñez‐Muñoz, R. J., & Dickson, G. (2016) · Human Gene Therapy · doi:10.1089/hum.2016.126
“Viruses were titrated for transducing units/mL by transduction with limiting dilutions and FACS, as previously described, 26 using the HT1080 cell line.”
Self-citationStrategies for the Gene Modification of Megakaryopoiesis and Platelets
Latorre-Rey, L. J., & Modlich, U. (2016) · Springer eBooks · doi:10.1007/978-3-319-39562-3_20
Optic nerve regeneration in adult rat
Hu, Y. (2006) · UWA Profiles and Research Repository (UWA)
MDS1/EVI1 and PRDM16 deregulation in hematopoiesis after experimental and clinical gene transfer
Wang, W. (2012) · heiDOK (Heidelberg University) · doi:10.11588/heidok.00013202
Odiba, A. S., Ottah, V., Anunobi, O. O., Ukegbu, C. Y., Uroko, R. I., Ottah, C., Edeke, A. A., & Omeje, K. O. (2017) · Egyptian Journal of Medical Human Genetics · doi:10.1016/j.ejmhg.2017.07.005 · Cited by 1
“Depending on the expected outcome of the experiments or trials involving gene transfer in post-mitotic tissues such as the insertion of the human RPE65 gene into the retina for the correction of Leber congenital amaurosis, non-integrating vectors can be made by generating integration-deficient lentiviral vectors (IDLV…”
BackgroundBiological Therapies for the Treatment of Cardiac Arrhythmias
Boveri, L., Colombi, B., & Priori, S. G. (2007)
Benati, D., Cocchiarella, F., & Recchia, A. (2018) · Journal of Visualized Experiments · doi:10.3791/56742
Integrated Biologics Manufacturing in Stirred-Suspension Bioreactor: A Stem Cell Perspective
Nath, S. C., & Rancourt, D. E. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.83813 · Cited by 1
Bringing balance to the force–regulatable gene therapy for epilepsy
Ruiz, A. J., & Rahim, A. A. (2019) · Gene Therapy · doi:10.1038/s41434-019-0083-6
Cockrell, A. S. (2011) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/t9n9-ct90
DETERMINANTS OF AAV TRANSPORT ACROSS THE BLOOD-BRAIN BARRIER
Albright, B. H. (2018) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/vnpr-wx33
Pharmacodynamic Evaluation: Gene Therapy
Grandchamp, N. (2020) · Springer eBooks · doi:10.1007/978-3-319-68864-0_51 · Cited by 1
Gene editing in PRKDC severe combined immunodeficiency and ataxia telangiectasia
Prakash, V. (2017) · Cited by 1
Optimisation of lentiviral vectors for gene therapy of spinal muscular atrophy
Nafchi, N. A. M. (2017)
An improved lentivirus vector for safer transgene integration and protein transduction
Schenkwein, D. (2013) · UEF eRepo (University of Eastern Finland)
Ginn, S. L., & Alexander, I. E. (2016) · Wiley eBooks · doi:10.1002/9781118445112.stat06926.pub2 · Cited by 3
Hengge, U. R. (2008) · Springer eBooks · doi:10.1007/978-3-540-69414-4_16
“Ein solcher Vektor führte in postmitotischen Geweben wie Augen und Gehirn von Nagetieren zur Langzeitexpression über mehrere Monate (Yanez-Munoz et al. 2006).”
BackgroundInfluentialSelectable Markers for Gene Therapy
Gillet, J., Hunt, R., Kimchi‐Sarfaty, C., Kafri, T., Zou, J., Rao, M. S., & Gottesman, M. M. (2015) · CRC Press eBooks · doi:10.1201/b18002-31
ARCOBALENO cell therapy to treat pediatric cancer patients
Presti, V. L. (2022) · Utrecht University Repository (Utrecht University) · doi:10.33540/1187
Ginn, S. L., & Alexander, I. E. (2008) · Wiley eBooks · doi:10.1002/9780471462422.eoct354
(2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2021
Ginn, S. L., & Alexander, I. E. (2014) · Wiley eBooks · doi:10.1002/9781118445112.stat06926
Ginn, S. L., & Alexander, I. E. (2005) · Wiley eBooks · doi:10.1002/0471667196.ess7172
Pharmacodynamic Evaluation: Gene Therapy
Grandchamp, N. (2019) · Springer eBooks · doi:10.1007/978-3-319-56637-5_51-1
Suresh, A. (2025) · OSF Preprints (OSF Preprints) · doi:10.31219/osf.io/8fyp7_v1
Hung, W. K., Chandrasekaran, S., Zaslaver, O., Ming, Z., Lam, J., Hersch, S. J., Mokarami, P., Slavcev, R. A., & Nafissi, N. (2025) · Scientific Reports · doi:10.1038/s41598-025-98730-5
Gene Therapy & Gene-Editing Techniques
LaRocca, C. J., & Steer, C. J. (2025) · Success in academic surgery · doi:10.1007/978-3-031-83034-1_13
Lentiviral Vector-Mediated Gene Delivery for iPSC-Related Neuroscience Research
Okunomiya, T., Imamura, K., Kashiyama, T., Sakurai, T., Hioki, H., & Inoue, H. (2025) · Methods in molecular biology · doi:10.1007/978-1-0716-4807-0_19
Properties and Application of Pseudotyped Lentiviral Vectors
Matsushita, N., Takada, M., & Kobayashi, K. (2025) · Methods in molecular biology · doi:10.1007/978-1-0716-4807-0_1
Lentiviral vectors for treatment of haemophilia
Ward, N. J. (2010) · UCL Discovery (University College London)
Etude de la restriction des cellules myeloïdes à l'infection lentivirale
Berger, G. (2011) · theses.fr (ABES) · doi:10.70675/5e6df030z045bz41b7z9b06z96a73dc15f6c
Interactions between primate lentiviral capsids and heterologous cellular host factors
Mamede, J. I. (2012) · theses.fr (ABES) · doi:10.70675/e3f4366bzb31fz4382z8f0cz19483f12bfe7
Renaud-Gabardos, E. (2016) · theses.fr (ABES) · doi:10.70675/6d9b4309za1adz4f4aza374zddc5391a757f
Dynamique et mécanique de complexes dystrophine-actine-lipides membranaires
Mias‐Lucquin, D. (2018) · theses.fr (ABES) · doi:10.70675/091e2702zc85fz4c91z908cz7e654aa5a3de
Gene therapy approach on Charcot-Marie-Tooth type 1A rats
Hajjar, H. (2018) · theses.fr (ABES) · doi:10.70675/014f2329za7dbz40a5z9c75z92e60af2b4a0 · Cited by 1
Application of lentiviral vector in vaccinology
Ku, M. (2020) · theses.fr (ABES) · doi:10.70675/18309422z66eez4f9fz9b16zd621476d44cd
Ghosh, D., Mayer-Hamblett, N., & Kaizer, A. M. (2026) · Journal of Biopharmaceutical Statistics · doi:10.1080/10543406.2026.2667329 · Cited by 1
From retina to brain: Viral tools for targeting retinal cells and mapping visual circuits
Talla, V., & Park, K. K. (2026) · Molecules and Cells · doi:10.1016/j.mocell.2026.100403
Development and application of non-integrating lentiviral vectors for gene therapy
Apolonia, L. (2009) · UCL Discovery (University College London) · Cited by 1
A study of intracoronary gene transfer using stents coated with plasmid vectors
Williams, P. D. (2011) · Research Explorer (The University of Manchester)
Trittibach, P. C., Barker, S. E., Broderick, C. A., Georgiadis, A., Durán, Y., Smith, A. J., & Ali, R. R. (2006) · Investigative Ophthalmology & Visual Science
Self-citationLariviere, W. R., & Cope, D. K. (2008) · Springer eBooks · doi:10.1007/978-0-387-78323-9_19
“Despite persistent transgene expression with AAV vectors, the possible risks associated with integration of AAV and lentiviruses into the host genome will likely remain a drawback for clinical applications (Pohl et al. 2003; Yanez-Munoz et al. 2006).”
Background
Metadata
- Authors
- Yáñez-Muñoz, R. J., Balaggan, K. S., MacNeil, A., Howe, S. J., Schmidt, M., Smith, A. J., Buch, P., MacLaren, R. E., Anderson, P. N., Barker, S. E., Duran, Y., Bartholomae, C., von Kalle, C., Heckenlively, J. R., Kinnon, C., Ali, R. R., & Thrasher, A. J.
- Affiliations
- University College London (GB)
- University of Freiburg (DE)
- Great Ormond Street Hospital (GB)
- Corresponding author
- Ali, Robin R
- ORCID
- Venue
- Nature Medicine
- Published
- 2006-02-19
- Volume
- 12
- Issue
- 3
- Pages
- 348-353
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- OpenAlex
- W2167845957
- Cited by
- 460
- References
- 30
- Citations by year
- 2026: 4 · 2025: 18 · 2024: 8 · 2023: 10 · 2022: 14 · 2021: 14 · 2020: 13 · 2019: 19 · 2018: 11 · 2017: 21 · 2016: 19 · 2015: 24 · 2014: 31 · 2013: 27 · 2012: 35
- FWCI
- 21.58
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Medicine (publishedVersion)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Research Portal (King's College London) (submittedVersion)
- Funders
- Wellcome Trust
- University College London
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
- Health Sciences › Medicine › Ophthalmology › Retinal Development and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Keywords
- insertional mutagenesis, retroviral vectors, stable transgene expression, ocular gene therapy, retinal degeneration, postmitotic tissues
- MeSH terms
- Retinoid Isomerohydrolase, Animals, Brain, Carrier Proteins, Electroretinography, Eye Proteins, Female, Genetic Vectors, HeLa Cells, Humans, Pigment Epithelium of Eye, Retina, Tumor Cells, Cultured, Genetic Therapy, Lentivirus, Virus Integration, cis-trans-Isomerases, Green Fluorescent Proteins, Mice, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.